NEW YORK -- (BUSINESS WIRE) -- Medivo, Inc., a health monitoring company and leader in lab data analytics, announced today that its co-founder, Jason Bhan, MD, will present at the 19th Annual Executive War College, the world’s largest annual gathering of laboratory and pathology leaders.
Dr. Bhan will speak during a breakout session entitled, “Using Sophisticated Reporting Tools and ‘Big Data’ Feeds of Lab Test Results to Generate New Revenue Streams for your Clinical Lab” on Tuesday, April 29, 2014 at 4:00pm CT. Gary S. Assarian, MS, DO, FCAP, a co-founder of The Joint Venture Hospital Laboratories (JVHL) in Michigan, will also participate in the session with Dr. Bhan.
During the session, Dr. Bhan will address the emergence of Big Data in healthcare and how labs can leverage this data to gain new insights into the lab marketplace as well as access new licensing and revenue opportunities. Dr. Assarian will review results from an ongoing Medivo / JVHL collaboration project.
Dr. Bhan is a Family Physician and serves as the Chief Medical Officer at Medivo. He is regarded as a national expert in the applications of technology to healthcare and medicine, a topic on which he speaks regularly at institutions and conferences, such as Health 2.0, mHealth, New York's eHealth Collaborative, and Health Datapalooza. He also has done extensive strategy consulting with pharmaceutical companies. From 2007-2010, Dr. Bhan worked with Clinovations and managed several large hospital system EHR implementations, outcomes measurements and data analysis. Dr. Bhan obtained his Doctor of Medicine at the University of Miami School of Medicine, and he is board certified in Family Medicine.
Dr. Assarian, in addition to his role at JVHL, is a consultant to BCBS, Trinity Health systems and the healthcare consulting groups Cognolink and Gerson Lehrman Group, Inc. He also serves on the Joint Uniform Medical Policy committee for BCBS/BCN for lab-related issues, and he is a member of NCQA’s Expert Lab Panel.
Executive War College 2014 will take place at the Sheraton Hotel in New Orleans on April 29-30. For more information, visit www.executivewarcollege.com.
Medivo unlocks the power of lab data to better inform treatment decisions and improve health outcomes. Our lab results search and lab analytics platform gives healthcare providers access to more complete patient and practice-level profiles sourced from 150+ labs, while our suite of mobile apps increase patient engagement and lab testing compliance. Our services enable physicians and payers to better track and improve outcomes, while providing services for Life Science companies to more effectively target and measure impact. Founded in 2010 by physicians and serial entrepreneurs, New York City-based Medivo’s investors include Safeguard Scientifics, Inc. (NYSE:SFE) and Merck Global Health Innovation Fund (GHIF). For more information, visit www.medivo.com.
Join Venture Hospital Laboratories (JVHL), which was established in 1992 to offer hospital and health system outreach laboratory programs, is organized as a limited liability company owned equally by several leading Michigan health care systems. More than 130 hospitals across Michigan, Ohio and Indiana participate in JVHL laboratory service agreements. A primary goal is to provide outpatient/outreach laboratory service relationships with payers to enable the network labs to provide services in support of local health care and physician organizations. JVHL’s Health Plan agreements cover 3.6 million members for outpatient and physician office laboratory services, and the JVHL Network Laboratories perform more than 30 million laboratory tests. Its network laboratories serve more than 12,000 physician clients through more than 400 patient service centers. For more information, visit www.jvhl.org.